Search Results 1631-1640 of 19630 for Hemoglobin

  1. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Hemoglobin \>= 9.0 g/dL (less than or equal to 28 days prior to registration) * Creatinine =\< 2 x upper limit of normal (ULN) (less than or equal to 28 ...

  3. Mayo Clinic Q and A: Functional dyspepsia can significantly affect quality of life

    Functional dyspepsia, also called nonulcer dyspepsia, and peptic ulcers can feel much the same. But, unlike a peptic ulcer, which involves open sores in the ...

  4. A Study to Evaluate the Effectiveness and Safety of Vedolizumab to Treat Chronic Pouchitis - Mayo Clinic

    Hemoglobin level < 8 g/dL. White blood cell (WBC) count < 3 × 10^9/L;; Lymphocyte count < 0.5 × 10^9/L;; Platelet count <100 × 10^9/L or > 1200 × 10^9/L ...

  5. Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas - Mayo Clinic

    Hemoglobin >= 9 g/dL (5.6 mmol/L). Subjects may not have had a transfusion within 7 days of screening assessment. Platelets >= 100 X 10^9/L. Subjects may not ...

  6. A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma - Mayo Clinic

    Hemoglobin < 8.0 g/dL;; Bilirubin > 1.5 x ULN (unless bilirubin rise is due to Gilbert's syndrome or of non-hepatic origin);; PT/INR > 1.5 x ULN and PTT (aPTT) ...

  7. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

    Hemoglobin ≥ 10.0 g/dL; note: this level may be reached by transfusion; Total bilirubin ≤ institutional upper limit of normal (ULN); Serum glutamic ...

  8. Neurosciences Clinical Trials - Medical Professionals

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. Mayo Clinic Minute: Are you using a salt substitute?

    Cutting back on salt helps lower your risk of heart disease but is using a salt substitute a better choice? Learn more from Mayo Clinic.

  10. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

    ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...